NCT00637715View on ClinicalTrials.gov

Once Daily Given Alfuzosin in the Treatment of BPH

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

December 31, 2004

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

Alfuzosin

Trial Locations (1)

Unknown

Sanofi-Aventis, Budapest

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00637715 - Once Daily Given Alfuzosin in the Treatment of BPH | Biotech Hunter | Biotech Hunter